GENO.ST
Genovis AB
Price:  
28.55 
SEK
Volume:  
39,564
Sweden | Life Sciences Tools & Services

GENO.ST DCF Valuation - Growth Exit 5Y

-47 %
Upside

What is the DCF valuation of GENO.ST?

The Discounted Cash Flow (DCF) valuation of Genovis AB (GENO.ST) is 15.14 SEK. With the latest stock price at 28.55 SEK, the upside of Genovis AB based on DCF is -47%.

Is GENO.ST a buy or a sell?

Based on the latest price of 28.55 SEK and our DCF valuation, Genovis AB (GENO.ST) is a sell. Selling GENO.ST stocks now will result in a potential gain of 47%.

Range Selected
WACC / Discount Rate5.1% - 8.2%6.7%
Long-term Growth Rate 3.0% - 4.9%3.9%
Fair Price8.78 - 146.6315.14
Upside-69.3% - 413.6%-47.0%
28.55 SEK
Stock Price
15.14 SEK
Fair Price
REVENUE & EXPENSES
CAPEX
D&A
WORKING CAPITAL
TERMINAL VALUE

GENO.ST DCF Valuation: Revenue & Expenses Forecast

(SEK in millions)Projections
12-202412-202512-202612-202712-202812-2029
Revenue130142182206227246
% Growth
18%9%28%13%10%9%
Cost of goods sold(46)(48)(58)(63)(65)(67)
% of Revenue35%34%32%30%29%27%
Selling, G&A expenses(45)(49)(62)(71)(78)(85)
% of Revenue34%34%34%34%34%34%
Research & Development000000
% of Revenue0%0%0%0%0%0%
Net interest & other expenses7810111213
% of Revenue5%5%5%5%5%5%
Tax expense(13)(15)(21)(24)(28)(31)
Tax rate29%29%29%29%29%29%
Net profit333850596876
% Margin25%27%28%29%30%31%